Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort
- 23 September 2014
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 54 (1) , 39-50
Abstract
Three studies have reported that BRCA1/2 mutations of paternal origin confer an earlier age at breast cancer diagnosis compared with maternal origin. The primary aim of this study was to investigate the impact of parental origin of BRCA1/2 mutations on age at breast and ovarian cancer diagnosis. This study included 577 female BRCA1/2 mutation carriers. All BRCA1/2 mutation carriers belonged to families registered between 1993 and 2011 at the Oncogenetic Clinic at Skånes University Hospital, Lund, Sweden. Cox proportional hazard ratios were used to analyze time to breast or ovarian cancer diagnosis. A novel finding was that carriers of BRCA1 mutations of paternal origin were 4 years older at age of ovarian cancer (P = 0.009) compared with those carrying a BRCA1 mutation of maternal origin. BRCA1 carriers with mutations of paternal origin were 4 years younger at breast cancer diagnosis (P = 0.017) compared with those carrying a BRCA1 mutation of maternal origin, which is in agreement with three previous studies. Both findings were adjusted for of year of inclusion, birth date, and oral contraceptive pill use. No associations between parental origin of BRCA2 mutations and time to breast or ovarian cancer diagnosis were found. An attempt to handle a potential selection bias regarding use of oral contraceptives was made using multiple imputations by chained equations. The observed age difference may allow a greater understanding of mechanisms associated with the differences in cancer penetrance in BRCA1/2 mutation carriers, some of which may depend on paternal origin.Keywords
Funding Information
- European Research Council (2011-294576)
- Cancerfonden (CAN 2012/741)
- Lunds Universitet (Doktorandmånader)
This publication has 45 references indexed in Scilit:
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer RiskPLOS Genetics, 2013
- Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersBreast Cancer Research, 2012
- Earlier age of onset of BRCA mutation‐related cancers in subsequent generationsCancer, 2011
- Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 CarriersCancer Epidemiology, Biomarkers & Prevention, 2011
- Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast CancerPLOS Genetics, 2011
- Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskHuman Molecular Genetics, 2011
- Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriersBreast Cancer Research and Treatment, 2009
- Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testingEuropean Journal of Cancer, 2005
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995